Pharmasmart completes initial testing phase for screening unit

ROCHESTER, N.Y. — PharmaSmart's PS2000 (D)estination completed its first alpha test inside a regional grocer, the company announced. Preliminary survey results received from the patients testing the unit inside the pharmacy reported that ease of use, ease of use, multi-biometric features, patented cuff size, virtual pharmacist and interoperability with pharmacy systems as the product's best features.



The company also said that the pharmacy staff overseeing the testing provided excellent anecdotal feedback regarding clinical features and benefit to healthcare objectives of their patients at point of care.



The company is targeting commercialization in late 2014 or early 2015. The PS2000 (D)estination will be showcased in booth #1727 at NACDS TSE.